Correlation Between GlaxoSmithKline PLC and Brown Advisory
Can any of the company-specific risk be diversified away by investing in both GlaxoSmithKline PLC and Brown Advisory at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining GlaxoSmithKline PLC and Brown Advisory into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between GlaxoSmithKline PLC ADR and Brown Advisory , you can compare the effects of market volatilities on GlaxoSmithKline PLC and Brown Advisory and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in GlaxoSmithKline PLC with a short position of Brown Advisory. Check out your portfolio center. Please also check ongoing floating volatility patterns of GlaxoSmithKline PLC and Brown Advisory.
Diversification Opportunities for GlaxoSmithKline PLC and Brown Advisory
0.83 | Correlation Coefficient |
Very poor diversification
The 3 months correlation between GlaxoSmithKline and Brown is 0.83. Overlapping area represents the amount of risk that can be diversified away by holding GlaxoSmithKline PLC ADR and Brown Advisory in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Brown Advisory and GlaxoSmithKline PLC is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on GlaxoSmithKline PLC ADR are associated (or correlated) with Brown Advisory. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Brown Advisory has no effect on the direction of GlaxoSmithKline PLC i.e., GlaxoSmithKline PLC and Brown Advisory go up and down completely randomly.
Pair Corralation between GlaxoSmithKline PLC and Brown Advisory
Considering the 90-day investment horizon GlaxoSmithKline PLC is expected to generate 3.81 times less return on investment than Brown Advisory. In addition to that, GlaxoSmithKline PLC is 1.58 times more volatile than Brown Advisory . It trades about 0.01 of its total potential returns per unit of risk. Brown Advisory is currently generating about 0.07 per unit of volatility. If you would invest 1,028 in Brown Advisory on August 26, 2024 and sell it today you would earn a total of 335.00 from holding Brown Advisory or generate 32.59% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Strong |
| Accuracy | 100.0% |
| Values | Daily Returns |
GlaxoSmithKline PLC ADR vs. Brown Advisory
Performance |
| Timeline |
| GlaxoSmithKline PLC ADR |
| Brown Advisory |
GlaxoSmithKline PLC and Brown Advisory Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with GlaxoSmithKline PLC and Brown Advisory
The main advantage of trading using opposite GlaxoSmithKline PLC and Brown Advisory positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if GlaxoSmithKline PLC position performs unexpectedly, Brown Advisory can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Brown Advisory will offset losses from the drop in Brown Advisory's long position.| GlaxoSmithKline PLC vs. Novartis AG ADR | GlaxoSmithKline PLC vs. AstraZeneca PLC ADR | GlaxoSmithKline PLC vs. Roche Holding Ltd | GlaxoSmithKline PLC vs. Bristol Myers Squibb |
| Brown Advisory vs. Brown Advisory Mid Cap | Brown Advisory vs. Brown Advisory Global | Brown Advisory vs. Brown Advisory Growth | Brown Advisory vs. Brown Advisory |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the CEOs Directory module to screen CEOs from public companies around the world.
Other Complementary Tools
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Stocks Directory Find actively traded stocks across global markets |